ベータラクタム＆ベータラクタマーゼ阻害剤のグローバル市場 2021年：企業別、地域別、種類・用途別

• 英文タイトル：Global Beta-lactam and Beta-lactamase Inhibitors Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-203B16064 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

ベータラクタム＆ベータラクタマーゼ阻害剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のベータラクタム＆ベータラクタマーゼ阻害剤の市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界のベータラクタム＆ベータラクタマーゼ阻害剤の市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 ベータラクタム＆ベータラクタマーゼ阻害剤市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・ペニシリン、セファロスポリン、カルバペネム、モノバクタム、複合物 用途別セグメントは次のように区分されます。 ・経口、静脈内 世界のベータラクタム＆ベータラクタマーゼ阻害剤市場の主要な市場プレーヤーは以下のとおりです。 ・Pfizer、Novartis (Sandoz)、TEVA、Merck、AbbVie (Allergan)、Sumitomo Dainippon、Hikma、Aurobindo Pharma、Wockhardt、Lupin Limited、Fresenius Kabi、B. Braun、USantibiotics、Qilu Pharmaceutical、ACS Dobfar、Nichi-Iko (Sagent)、Antibiotice 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、ベータラクタム＆ベータラクタマーゼ阻害剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なベータラクタム＆ベータラクタマーゼ阻害剤メーカーの企業概要、2019年～2021年までのベータラクタム＆ベータラクタマーゼ阻害剤の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なベータラクタム＆ベータラクタマーゼ阻害剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別ベータラクタム＆ベータラクタマーゼ阻害剤の販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までのベータラクタム＆ベータラクタマーゼ阻害剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域でのベータラクタム＆ベータラクタマーゼ阻害剤市場予測を収録しています。 ・第12、13、14章では、ベータラクタム＆ベータラクタマーゼ阻害剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、Novartis (Sandoz)、TEVA、Merck、AbbVie (Allergan)、Sumitomo Dainippon、Hikma、Aurobindo Pharma、Wockhardt、Lupin Limited、Fresenius Kabi、B. Braun、USantibiotics、Qilu Pharmaceutical、ACS Dobfar、Nichi-Iko (Sagent)、Antibiotice ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ペニシリン、セファロスポリン、カルバペネム、モノバクタム、複合物 ・用途別分析2016年-2026年：経口、静脈内 ・ベータラクタム＆ベータラクタマーゼ阻害剤の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ベータラクタム＆ベータラクタマーゼ阻害剤のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ベータラクタム＆ベータラクタマーゼ阻害剤のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ベータラクタム＆ベータラクタマーゼ阻害剤の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ベータラクタム＆ベータラクタマーゼ阻害剤の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Beta-lactam and Beta-lactamase Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Beta-lactam and Beta-lactamase Inhibitors size is estimated to be million in 2021 from USD 24400 million in 2020, with a change of % between 2020 and 2021. The global Beta-lactam and Beta-lactamase Inhibitors market size is expected to grow at a CAGR of 1.8% for the next five years.

Market segmentation
Beta-lactam and Beta-lactamase Inhibitors market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Penicillins
Cephalosporins
Carbapenems
Monobactams
Combinations

Market segment by Application can be divided into
Oral
Intravenous

The key market players for global Beta-lactam and Beta-lactamase Inhibitors market are listed below:
Pfizer
Novartis (Sandoz)
TEVA
Merck
AbbVie (Allergan)
Sumitomo Dainippon
Hikma
Aurobindo Pharma
Wockhardt
Lupin Limited
Fresenius Kabi
B. Braun
USantibiotics
Qilu Pharmaceutical
ACS Dobfar
Nichi-Iko (Sagent)
Antibiotice

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Beta-lactam and Beta-lactamase Inhibitors product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Beta-lactam and Beta-lactamase Inhibitors, with price, sales, revenue and global market share of Beta-lactam and Beta-lactamase Inhibitors from 2019 to 2021.
Chapter 3, the Beta-lactam and Beta-lactamase Inhibitors competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Beta-lactam and Beta-lactamase Inhibitors breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Beta-lactam and Beta-lactamase Inhibitors market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Beta-lactam and Beta-lactamase Inhibitors sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Beta-lactam and Beta-lactamase Inhibitors Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Beta-lactam and Beta-lactamase Inhibitors Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Penicillins
1.2.3 Cephalosporins
1.2.4 Carbapenems
1.2.5 Monobactams
1.2.6 Combinations
1.3 Market Analysis by Application
1.3.1 Overview: Global Beta-lactam and Beta-lactamase Inhibitors Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Oral
1.3.3 Intravenous
1.4 Global Beta-lactam and Beta-lactamase Inhibitors Market Size & Forecast
1.4.1 Global Beta-lactam and Beta-lactamase Inhibitors Sales in Value (2016-2026))
1.4.2 Global Beta-lactam and Beta-lactamase Inhibitors Sales in Volume (2016-2026)
1.4.3 Global Beta-lactam and Beta-lactamase Inhibitors Price by Type (2016-2026) & (US$/Unit)
1.5 Global Beta-lactam and Beta-lactamase Inhibitors Production Capacity Analysis
1.5.1 Global Beta-lactam and Beta-lactamase Inhibitors Total Production Capacity (2016-2026)
1.5.2 Global Beta-lactam and Beta-lactamase Inhibitors Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Beta-lactam and Beta-lactamase Inhibitors Market Drivers
1.6.2 Beta-lactam and Beta-lactamase Inhibitors Market Restraints
1.6.3 Beta-lactam and Beta-lactamase Inhibitors Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Beta-lactam and Beta-lactamase Inhibitors Product and Services
2.1.4 Pfizer Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Novartis (Sandoz)
2.2.1 Novartis (Sandoz) Details
2.2.2 Novartis (Sandoz) Major Business
2.2.3 Novartis (Sandoz) Beta-lactam and Beta-lactamase Inhibitors Product and Services
2.2.4 Novartis (Sandoz) Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 TEVA
2.3.1 TEVA Details
2.3.2 TEVA Major Business
2.3.3 TEVA Beta-lactam and Beta-lactamase Inhibitors Product and Services
2.3.4 TEVA Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Beta-lactam and Beta-lactamase Inhibitors Product and Services
2.4.4 Merck Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 AbbVie (Allergan)
2.5.1 AbbVie (Allergan) Details
2.5.2 AbbVie (Allergan) Major Business
2.5.3 AbbVie (Allergan) Beta-lactam and Beta-lactamase Inhibitors Product and Services
2.5.4 AbbVie (Allergan) Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Sumitomo Dainippon
2.6.1 Sumitomo Dainippon Details
2.6.2 Sumitomo Dainippon Major Business
2.6.3 Sumitomo Dainippon Beta-lactam and Beta-lactamase Inhibitors Product and Services
2.6.4 Sumitomo Dainippon Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Hikma
2.7.1 Hikma Details
2.7.2 Hikma Major Business
2.7.3 Hikma Beta-lactam and Beta-lactamase Inhibitors Product and Services
2.7.4 Hikma Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Aurobindo Pharma
2.8.1 Aurobindo Pharma Details
2.8.2 Aurobindo Pharma Major Business
2.8.3 Aurobindo Pharma Beta-lactam and Beta-lactamase Inhibitors Product and Services
2.8.4 Aurobindo Pharma Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Wockhardt
2.9.1 Wockhardt Details
2.9.2 Wockhardt Major Business
2.9.3 Wockhardt Beta-lactam and Beta-lactamase Inhibitors Product and Services
2.9.4 Wockhardt Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Lupin Limited
2.10.1 Lupin Limited Details
2.10.2 Lupin Limited Major Business
2.10.3 Lupin Limited Beta-lactam and Beta-lactamase Inhibitors Product and Services
2.10.4 Lupin Limited Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Fresenius Kabi
2.11.1 Fresenius Kabi Details
2.11.2 Fresenius Kabi Major Business
2.11.3 Fresenius Kabi Beta-lactam and Beta-lactamase Inhibitors Product and Services
2.11.4 Fresenius Kabi Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 B. Braun
2.12.1 B. Braun Details
2.12.2 B. Braun Major Business
2.12.3 B. Braun Beta-lactam and Beta-lactamase Inhibitors Product and Services
2.12.4 B. Braun Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 USantibiotics
2.13.1 USantibiotics Details
2.13.2 USantibiotics Major Business
2.13.3 USantibiotics Beta-lactam and Beta-lactamase Inhibitors Product and Services
2.13.4 USantibiotics Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Qilu Pharmaceutical
2.14.1 Qilu Pharmaceutical Details
2.14.2 Qilu Pharmaceutical Major Business
2.14.3 Qilu Pharmaceutical Beta-lactam and Beta-lactamase Inhibitors Product and Services
2.14.4 Qilu Pharmaceutical Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 ACS Dobfar
2.15.1 ACS Dobfar Details
2.15.2 ACS Dobfar Major Business
2.15.3 ACS Dobfar Beta-lactam and Beta-lactamase Inhibitors Product and Services
2.15.4 ACS Dobfar Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Nichi-Iko (Sagent)
2.16.1 Nichi-Iko (Sagent) Details
2.16.2 Nichi-Iko (Sagent) Major Business
2.16.3 Nichi-Iko (Sagent) Beta-lactam and Beta-lactamase Inhibitors Product and Services
2.16.4 Nichi-Iko (Sagent) Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 Antibiotice
2.17.1 Antibiotice Details
2.17.2 Antibiotice Major Business
2.17.3 Antibiotice Beta-lactam and Beta-lactamase Inhibitors Product and Services
2.17.4 Antibiotice Beta-lactam and Beta-lactamase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Beta-lactam and Beta-lactamase Inhibitors Sales by Manufacturer
3.1 Global Beta-lactam and Beta-lactamase Inhibitors Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Beta-lactam and Beta-lactamase Inhibitors Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Beta-lactam and Beta-lactamase Inhibitors
3.4 Market Concentration Rate
3.4.1 Top 3 Beta-lactam and Beta-lactamase Inhibitors Manufacturer Market Share
3.4.2 Top 6 Beta-lactam and Beta-lactamase Inhibitors Manufacturer Market Share
3.5 Global Beta-lactam and Beta-lactamase Inhibitors Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Beta-lactam and Beta-lactamase Inhibitors Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Size by Region
4.1.1 Global Beta-lactam and Beta-lactamase Inhibitors Sales in Volume by Region (2016-2026)
4.1.2 Global Beta-lactam and Beta-lactamase Inhibitors Revenue by Region (2016-2026)
4.2 North America Beta-lactam and Beta-lactamase Inhibitors Revenue (2016-2026)
4.3 Europe Beta-lactam and Beta-lactamase Inhibitors Revenue (2016-2026)
4.4 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Revenue (2016-2026)
4.5 South America Beta-lactam and Beta-lactamase Inhibitors Revenue (2016-2026)
4.6 Middle East and Africa Beta-lactam and Beta-lactamase Inhibitors Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Beta-lactam and Beta-lactamase Inhibitors Sales in Volume by Type (2016-2026)
5.2 Global Beta-lactam and Beta-lactamase Inhibitors Revenue by Type (2016-2026)
5.3 Global Beta-lactam and Beta-lactamase Inhibitors Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Beta-lactam and Beta-lactamase Inhibitors Sales in Volume by Application (2016-2026)
6.2 Global Beta-lactam and Beta-lactamase Inhibitors Revenue by Application (2016-2026)
6.3 Global Beta-lactam and Beta-lactamase Inhibitors Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Beta-lactam and Beta-lactamase Inhibitors Sales by Type (2016-2026)
7.2 North America Beta-lactam and Beta-lactamase Inhibitors Sales by Application (2016-2026)
7.3 North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Country
7.3.1 North America Beta-lactam and Beta-lactamase Inhibitors Sales in Volume by Country (2016-2026)
7.3.2 North America Beta-lactam and Beta-lactamase Inhibitors Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Beta-lactam and Beta-lactamase Inhibitors Sales by Type (2016-2026)
8.2 Europe Beta-lactam and Beta-lactamase Inhibitors Sales by Application (2016-2026)
8.3 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Country
8.3.1 Europe Beta-lactam and Beta-lactamase Inhibitors Sales in Volume by Country (2016-2026)
8.3.2 Europe Beta-lactam and Beta-lactamase Inhibitors Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Sales by Type (2016-2026)
9.2 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Sales by Application (2016-2026)
9.3 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Region
9.3.1 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Beta-lactam and Beta-lactamase Inhibitors Sales by Type (2016-2026)
10.2 South America Beta-lactam and Beta-lactamase Inhibitors Sales by Application (2016-2026)
10.3 South America Beta-lactam and Beta-lactamase Inhibitors Market Size by Country
10.3.1 South America Beta-lactam and Beta-lactamase Inhibitors Sales in Volume by Country (2016-2026)
10.3.2 South America Beta-lactam and Beta-lactamase Inhibitors Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Sales by Type (2016-2026)
11.2 Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Sales by Application (2016-2026)
11.3 Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Country
11.3.1 Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Beta-lactam and Beta-lactamase Inhibitors Typical Distributors
12.3 Beta-lactam and Beta-lactamase Inhibitors Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Beta-lactam and Beta-lactamase Inhibitors Revenue by Type, (USD Million), 2021-2026
Table 2. Global Beta-lactam and Beta-lactamase Inhibitors Revenue by Application, (USD Million), 2021-2026
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Beta-lactam and Beta-lactamase Inhibitors Product and Services
Table 6. Pfizer Beta-lactam and Beta-lactamase Inhibitors Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Novartis (Sandoz) Basic Information, Manufacturing Base and Competitors
Table 8. Novartis (Sandoz) Major Business
Table 9. Novartis (Sandoz) Beta-lactam and Beta-lactamase Inhibitors Product and Services
Table 10. Novartis (Sandoz) Beta-lactam and Beta-lactamase Inhibitors Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. TEVA Basic Information, Manufacturing Base and Competitors
Table 12. TEVA Major Business
Table 13. TEVA Beta-lactam and Beta-lactamase Inhibitors Product and Services
Table 14. TEVA Beta-lactam and Beta-lactamase Inhibitors Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Merck Basic Information, Manufacturing Base and Competitors
Table 16. Merck Major Business
Table 17. Merck Beta-lactam and Beta-lactamase Inhibitors Product and Services
Table 18. Merck Beta-lactam and Beta-lactamase Inhibitors Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. AbbVie (Allergan) Basic Information, Manufacturing Base and Competitors
Table 20. AbbVie (Allergan) Major Business
Table 21. AbbVie (Allergan) Beta-lactam and Beta-lactamase Inhibitors Product and Services
Table 22. AbbVie (Allergan) Beta-lactam and Beta-lactamase Inhibitors Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Sumitomo Dainippon Basic Information, Manufacturing Base and Competitors
Table 24. Sumitomo Dainippon Major Business
Table 25. Sumitomo Dainippon Beta-lactam and Beta-lactamase Inhibitors Product and Services
Table 26. Sumitomo Dainippon Beta-lactam and Beta-lactamase Inhibitors Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Hikma Basic Information, Manufacturing Base and Competitors
Table 28. Hikma Major Business
Table 29. Hikma Beta-lactam and Beta-lactamase Inhibitors Product and Services
Table 30. Hikma Beta-lactam and Beta-lactamase Inhibitors Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 32. Aurobindo Pharma Major Business
Table 33. Aurobindo Pharma Beta-lactam and Beta-lactamase Inhibitors Product and Services
Table 34. Aurobindo Pharma Beta-lactam and Beta-lactamase Inhibitors Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Wockhardt Basic Information, Manufacturing Base and Competitors
Table 36. Wockhardt Major Business
Table 37. Wockhardt Beta-lactam and Beta-lactamase Inhibitors Product and Services
Table 38. Wockhardt Beta-lactam and Beta-lactamase Inhibitors Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Lupin Limited Basic Information, Manufacturing Base and Competitors
Table 40. Lupin Limited Major Business
Table 41. Lupin Limited Beta-lactam and Beta-lactamase Inhibitors Product and Services
Table 42. Lupin Limited Beta-lactam and Beta-lactamase Inhibitors Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 44. Fresenius Kabi Major Business
Table 45. Fresenius Kabi Beta-lactam and Beta-lactamase Inhibitors Product and Services
Table 46. Fresenius Kabi Beta-lactam and Beta-lactamase Inhibitors Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. B. Braun Basic Information, Manufacturing Base and Competitors
Table 48. B. Braun Major Business
Table 49. B. Braun Beta-lactam and Beta-lactamase Inhibitors Product and Services
Table 50. B. Braun Beta-lactam and Beta-lactamase Inhibitors Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. USantibiotics Basic Information, Manufacturing Base and Competitors
Table 52. USantibiotics Major Business
Table 53. USantibiotics Beta-lactam and Beta-lactamase Inhibitors Product and Services
Table 54. USantibiotics Beta-lactam and Beta-lactamase Inhibitors Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 56. Qilu Pharmaceutical Major Business
Table 57. Qilu Pharmaceutical Beta-lactam and Beta-lactamase Inhibitors Product and Services
Table 58. Qilu Pharmaceutical Beta-lactam and Beta-lactamase Inhibitors Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. ACS Dobfar Basic Information, Manufacturing Base and Competitors
Table 60. ACS Dobfar Major Business
Table 61. ACS Dobfar Beta-lactam and Beta-lactamase Inhibitors Product and Services
Table 62. ACS Dobfar Beta-lactam and Beta-lactamase Inhibitors Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Nichi-Iko (Sagent) Basic Information, Manufacturing Base and Competitors
Table 64. Nichi-Iko (Sagent) Major Business
Table 65. Nichi-Iko (Sagent) Beta-lactam and Beta-lactamase Inhibitors Product and Services
Table 66. Nichi-Iko (Sagent) Beta-lactam and Beta-lactamase Inhibitors Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Antibiotice Basic Information, Manufacturing Base and Competitors
Table 68. Antibiotice Major Business
Table 69. Antibiotice Beta-lactam and Beta-lactamase Inhibitors Product and Services
Table 70. Antibiotice Beta-lactam and Beta-lactamase Inhibitors Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Global Beta-lactam and Beta-lactamase Inhibitors Sales by Manufacturer (2019-2021e) & (M Units)
Table 72. Global Beta-lactam and Beta-lactamase Inhibitors Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 73. Market Position of Manufacturers in Beta-lactam and Beta-lactamase Inhibitors, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 74. Global Beta-lactam and Beta-lactamase Inhibitors Production Capacity by Company, (M Units): 2020 VS 2021
Table 75. Head Office and Beta-lactam and Beta-lactamase Inhibitors Production Site of Key Manufacturer
Table 76. Beta-lactam and Beta-lactamase Inhibitors New Entrant and Capacity Expansion Plans
Table 77. Beta-lactam and Beta-lactamase Inhibitors Mergers & Acquisitions in the Past Five Years
Table 78. Global Beta-lactam and Beta-lactamase Inhibitors Sales by Region (2016-2021e) & (M Units)
Table 79. Global Beta-lactam and Beta-lactamase Inhibitors Sales by Region (2021-2026) & (M Units)
Table 80. Global Beta-lactam and Beta-lactamase Inhibitors Revenue by Region (2016-2021e) & (USD Million)
Table 81. Global Beta-lactam and Beta-lactamase Inhibitors Revenue by Region (2021-2026) & (USD Million)
Table 82. Global Beta-lactam and Beta-lactamase Inhibitors Sales by Type (2016-2021e) & (M Units)
Table 83. Global Beta-lactam and Beta-lactamase Inhibitors Sales by Type (2021-2026) & (M Units)
Table 84. Global Beta-lactam and Beta-lactamase Inhibitors Revenue by Type (2016-2021e) & (USD Million)
Table 85. Global Beta-lactam and Beta-lactamase Inhibitors Revenue by Type (2021-2026) & (USD Million)
Table 86. Global Beta-lactam and Beta-lactamase Inhibitors Price by Type (2016-2021e) & (US$/Unit)
Table 87. Global Beta-lactam and Beta-lactamase Inhibitors Price by Type (2021-2026) & (US$/Unit)
Table 88. Global Beta-lactam and Beta-lactamase Inhibitors Sales by Application (2016-2021e) & (M Units)
Table 89. Global Beta-lactam and Beta-lactamase Inhibitors Sales by Application (2021-2026) & (M Units)
Table 90. Global Beta-lactam and Beta-lactamase Inhibitors Revenue by Application (2016-2021e) & (USD Million)
Table 91. Global Beta-lactam and Beta-lactamase Inhibitors Revenue by Application (2021-2026) & (USD Million)
Table 92. Global Beta-lactam and Beta-lactamase Inhibitors Price by Application (2016-2021e) & (US$/Unit)
Table 93. Global Beta-lactam and Beta-lactamase Inhibitors Price by Application (2021-2026) & (US$/Unit)
Table 94. North America Beta-lactam and Beta-lactamase Inhibitors Sales by Country (2016-2021e) & (M Units)
Table 95. North America Beta-lactam and Beta-lactamase Inhibitors Sales by Country (2021-2026) & (M Units)
Table 96. North America Beta-lactam and Beta-lactamase Inhibitors Revenue by Country (2016-2021e) & (USD Million)
Table 97. North America Beta-lactam and Beta-lactamase Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 98. North America Beta-lactam and Beta-lactamase Inhibitors Sales by Type (2016-2021e) & (M Units)
Table 99. North America Beta-lactam and Beta-lactamase Inhibitors Sales by Type (2021-2026) & (M Units)
Table 100. North America Beta-lactam and Beta-lactamase Inhibitors Sales by Application (2016-2021e) & (M Units)
Table 101. North America Beta-lactam and Beta-lactamase Inhibitors Sales by Application (2021-2026) & (M Units)
Table 102. Europe Beta-lactam and Beta-lactamase Inhibitors Sales by Country (2016-2021e) & (M Units)
Table 103. Europe Beta-lactam and Beta-lactamase Inhibitors Sales by Country (2021-2026) & (M Units)
Table 104. Europe Beta-lactam and Beta-lactamase Inhibitors Revenue by Country (2016-2021e) & (USD Million)
Table 105. Europe Beta-lactam and Beta-lactamase Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 106. Europe Beta-lactam and Beta-lactamase Inhibitors Sales by Type (2016-2021e) & (M Units)
Table 107. Europe Beta-lactam and Beta-lactamase Inhibitors Sales by Type (2021-2026) & (M Units)
Table 108. Europe Beta-lactam and Beta-lactamase Inhibitors Sales by Application (2016-2021e) & (M Units)
Table 109. Europe Beta-lactam and Beta-lactamase Inhibitors Sales by Application (2021-2026) & (M Units)
Table 110. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Sales by Region (2016-2021e) & (M Units)
Table 111. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Sales by Region (2021-2026) & (M Units)
Table 112. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Revenue by Region (2016-2021e) & (USD Million)
Table 113. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Revenue by Region (2021-2026) & (USD Million)
Table 114. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Sales by Type (2016-2021e) & (M Units)
Table 115. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Sales by Type (2021-2026) & (M Units)
Table 116. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Sales by Application (2016-2021e) & (M Units)
Table 117. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Sales by Application (2021-2026) & (M Units)
Table 118. South America Beta-lactam and Beta-lactamase Inhibitors Sales by Country (2016-2021e) & (M Units)
Table 119. South America Beta-lactam and Beta-lactamase Inhibitors Sales by Country (2021-2026) & (M Units)
Table 120. South America Beta-lactam and Beta-lactamase Inhibitors Revenue by Country (2016-2021e) & (USD Million)
Table 121. South America Beta-lactam and Beta-lactamase Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 122. South America Beta-lactam and Beta-lactamase Inhibitors Sales by Type (2016-2021e) & (M Units)
Table 123. South America Beta-lactam and Beta-lactamase Inhibitors Sales by Type (2021-2026) & (M Units)
Table 124. South America Beta-lactam and Beta-lactamase Inhibitors Sales by Application (2016-2021e) & (M Units)
Table 125. South America Beta-lactam and Beta-lactamase Inhibitors Sales by Application (2021-2026) & (M Units)
Table 126. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Sales by Country (2016-2021e) & (M Units)
Table 127. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Sales by Country (2021-2026) & (M Units)
Table 128. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Revenue by Country (2016-2021e) & (USD Million)
Table 129. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 130. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Sales by Type (2016-2021e) & (M Units)
Table 131. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Sales by Type (2021-2026) & (M Units)
Table 132. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Sales by Application (2016-2021e) & (M Units)
Table 133. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Sales by Application (2021-2026) & (M Units)
Table 134. Direct Channel Pros & Cons
Table 135. Indirect Channel Pros & Cons
Table 136. Beta-lactam and Beta-lactamase Inhibitors Typical Distributors
Table 137. Beta-lactam and Beta-lactamase Inhibitors Typical Customers
List of Figures
Figure 1. Beta-lactam and Beta-lactamase Inhibitors Picture
Figure 2. Global Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Type in 2020
Figure 3. Penicillins
Figure 4. Cephalosporins
Figure 5. Carbapenems
Figure 6. Monobactams
Figure 7. Combinations
Figure 8. Global Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Application in 2020
Figure 9. Oral
Figure 10. Intravenous
Figure 11. Global Beta-lactam and Beta-lactamase Inhibitors Market Size, (USD Million) & (M Units): 2020 VS 2021 VS 2026
Figure 12. Global Beta-lactam and Beta-lactamase Inhibitors Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. Global Beta-lactam and Beta-lactamase Inhibitors Sales (2016-2026) & (M Units)
Figure 14. Global Beta-lactam and Beta-lactamase Inhibitors Price by Type (2016-2026) & (US$/Unit)
Figure 15. Global Beta-lactam and Beta-lactamase Inhibitors Production Capacity (2016-2026) & (M Units)
Figure 16. Global Beta-lactam and Beta-lactamase Inhibitors Production Capacity by Geographic Region: 2020 VS 2021
Figure 17. Beta-lactam and Beta-lactamase Inhibitors Market Drivers
Figure 18. Beta-lactam and Beta-lactamase Inhibitors Market Restraints
Figure 19. Beta-lactam and Beta-lactamase Inhibitors Market Trends
Figure 20. Global Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Manufacturer in 2020
Figure 21. Global Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Manufacturer in 2020
Figure 22. Beta-lactam and Beta-lactamase Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. Top 3 Beta-lactam and Beta-lactamase Inhibitors Manufacturer (Revenue) Market Share in 2020
Figure 24. Top 6 Beta-lactam and Beta-lactamase Inhibitors Manufacturer (Revenue) Market Share in 2020
Figure 25. Global Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Region (2016-2026)
Figure 26. Global Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Region (2016-2026)
Figure 27. North America Beta-lactam and Beta-lactamase Inhibitors Revenue (2016-2026) & (USD Million)
Figure 28. Europe Beta-lactam and Beta-lactamase Inhibitors Revenue (2016-2026) & (USD Million)
Figure 29. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Revenue (2016-2026) & (USD Million)
Figure 30. South America Beta-lactam and Beta-lactamase Inhibitors Revenue (2016-2026) & (USD Million)
Figure 31. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Revenue (2016-2026) & (USD Million)
Figure 32. Global Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Type (2016-2026)
Figure 33. Global Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Type (2016-2026)
Figure 34. Global Beta-lactam and Beta-lactamase Inhibitors Price by Type (2016-2026) & (US$/Unit)
Figure 35. Global Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Application (2016-2026)
Figure 36. Global Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Application (2016-2026)
Figure 37. Global Beta-lactam and Beta-lactamase Inhibitors Price by Application (2016-2026) & (US$/Unit)
Figure 38. North America Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Type (2016-2026)
Figure 39. North America Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Application (2016-2026)
Figure 40. North America Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Country (2016-2026)
Figure 41. North America Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Country (2016-2026)
Figure 42. United States Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Type (2016-2026)
Figure 46. Europe Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Application (2016-2026)
Figure 47. Europe Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Country (2016-2026)
Figure 48. Europe Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Country (2016-2026)
Figure 49. Germany Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Region (2016-2026)
Figure 58. China Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Korea Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Type (2016-2026)
Figure 65. South America Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Application (2016-2026)
Figure 66. South America Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Country (2016-2026)
Figure 67. South America Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Type (2016-2026)
Figure 71. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Egypt Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. South Africa Beta-lactam and Beta-lactamase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source

---